The first line of evidence showed that ADK expression was significantly increased in liver cells, predominantly hepatocytes, in human subjects with non-alcoholic fatty liver disease (now MASLD) (including MASH) and in a mouse model with diet-induced obesity and MASLD [2]. The gene discussed is ADK; the disease is metabolic dysfunction-associated steatotic liver disease.